Arkolith/Insider Trading/DMAC/Form 4

Giuffre Randall Michael

DirectorDiaMedica Therapeutics Inc. (DMAC) · full profile →Form 4 · filed Feb 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2025Option exercise(M)12K$2.11$25K387K
Feb 13, 2025Option exercise(M)5K$3.65$18K392K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2025Option exercise(M)12K—$00
Feb 13, 2025Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-25-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML